Development of a Novel Combination Therapy targeting MET and LGR5 to overcome Colorectal Cancer Resistance

Authors

Shraddha Subramanian, University of Texas MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences
Tressie Posey, University of Texas MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences
Joan Jacob, University of Texas MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences
Kendra S. Carmon, University of Texas MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences

Files

Abstract

View full abstract

DOI

https://doi.org/10.52519/00086

Publication Date

2022

Department

Translational Cancer Research

Research Category

Other

Recommended Citation

Subramanian, Shraddha; Posey, Tressie; Jacob, Joan; and Carmon, Kendra S., "Development of a Novel Combination Therapy targeting MET and LGR5 to overcome Colorectal Cancer Resistance" (2022). Leading Edge of Cancer Research Symposium. 27.
doi:https://doi.org/10.52519/00086